共 74 条
[1]
Illanes S(2011)Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage Stroke 42 191-195
[2]
Zhou W(2016)Contemporary developments in the discovery of selective factor Xa inhibitors: a review Eur J Med Chem 121 671-698
[3]
Schwarting S(2007)Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 857-867
[4]
Heiland S(2012)A new era for anticoagulation in atrial fibrillation which anticoagulant should we choose for long-term prevention of thromboembolic complications in patients with atrial fibrillation? Pol Arch Med Wewn 122 45-52
[5]
Veltkamp R(2016)Novel oral anticoagulants for heparin-induced thrombocytopenia J Thromb Thrombolys. 42 172-178
[6]
Patel NR(2015)Thrombocytopenia possibly induced by dabigatran: a case report Aust J Pharm 3 1000170-1889
[7]
Patel DV(2010)Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin Arterioscl Throm Vas 30 1885-205
[8]
Murumkar PR(2015)Design and rationale for RE-VERSE AD: a phase 3 study of idarucizumab, a specific reversal agent for dabigatran Thromb Haemost 114 198-1848
[9]
Yadav MR(2012)Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model J Thromb Haemost 10 1841-8
[10]
Hart RG(2013)The discovery of dabigatran etexilate Front Pharmacol 4 1-159